http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1910202-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da04b40384f30a62c8c906c771d576f6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2003-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c52a0d482923c72026dcae0a5a9862 |
publicationDate | 2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-1910202-A |
titleOfInvention | 98P4B6 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
abstract | A novel gene 08P1D4 (also designated STEAP-1) and its encoded protein, and variants thereof, are described wherein STEAP-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, STEAP-1 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The STEAP-1 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with STEAP-1 can be used in active or passive immunization. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111949888-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111949888-B |
priorityDate | 2002-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1464.